Takeda.com - SEO Checker

Sign up for free! PDF Export
Overview of the SEO Check
Meta information
100% 
Page quality
61% 
Page structure
100% 
Link structure
70% 
Server
91% 
External factors
100% 
SEO Score
Response time
0.27 s
File size
439.80 kB
Words
485
Media files
6
Number of links
91 internal / 2 external

Task list of SEO Improvements

Meta specifications

Title
(Critically important)
Takeda Pharmaceuticals: Global Homepage
The length of the page title is perfect. (394 pixels out of 580 max pixel length)
There are no duplicate words in the title
Meta description
(Critically important)
Takeda is a patient-focused, R&D-driven global biopharmaceutical company committed to bringing Better Health and a Brighter Future.
The length of the meta description is perfect. (830 pixels out of 1000 max pixel length)
Crawlability
(Critically important)
There are no problems in accessing the website.
Canonical URL
(Important)
https://www.takeda.com/
There is a valid canonical link specified.
Language
(Somewhat important)
Language detected in text: en
Language defined in HTML: en
Server location: United States of America
The following language is defined by HTML: en
Alternate/Hreflang Links
(Somewhat important)
The specified alternate links have no errors.
Other meta tags
(Somewhat important)
There is no rel next meta tag on this page.
There is no rel prev meta tag on this page.
Domain
(Somewhat important)
The domain is no subdomain.
The domain length is good.
The domain does not contain non-latin characters.
Page URL
(Somewhat important)
No parameters were found in the URL.
No session ID was found in the URL.
The URL does not have too many subdirectories.
Charset encoding
(Somewhat important)
The charset encoding (UTF-8) is set correctly.
Doctype
(Nice to have)
The doctype HTML 5 is set correctly.
The doctype is placed at first in the HTML code.
Favicon
(Nice to have)
The favicon is linked correctly.

Meta tags

NameValue
viewportuser-scalable=yes, width=device-width, initial-scale=1, maximum-scale=2, viewport-fit=cover
robotsindex,follow
descriptionTakeda is a patient-focused, R&D-driven global biopharmaceutical company committed to bringing Better Health and a Brighter Future.
next-head-count26
langen
og:titleTakeda Pharmaceuticals: Global Homepage
og:descriptionTakeda is a patient-focused, R&D-driven global biopharmaceutical company committed to bringing Better Health and a Brighter Future.
og:urlhttps://www.takeda.com/
og:imagehttp://assets-dam.takeda.com/image/upload/v1683892920/Global/OG%20Logo.jpg
og:image:altTakeda Pharmaceuticals: Global Homepage
og:image:secure_urlhttps://assets-dam.takeda.com/image/upload/v1683892920/Global/OG%20Logo.jpg
og:image:typeimage
og:image:width1200
og:image:height627
charsetutf-8

Test up to 1.000 webpages of takeda.com with our free plan!

Try For Free
No trial. It's just free!

Page quality

Content
(Critically important)
Words from the H1 heading are not used in the page content.
There are only 485 words on this page. Good pages should have about 800 words of useful content.
24.1% of the text are stop words.
Keywords used in the page title are also used in the page content. That's good!
The page contains a listing, which indicates a good text layout.
7 paragraphs were found on this page.
No placeholders texts or images were found.
There are no duplicates on the site.
The average number of words per sentence of 17.88 words is good.
Frames
(Critically important)
This page does not use a frameset.
Mobile optimization
(Somewhat important)
A viewport "user-scalable=yes, width=device-width, initial-scale=1, maximum-scale=2, viewport-fit=cover" is provided.
At least one Apple touch icon is specified.
Bold and strong tags
(Somewhat important)
The following tag is repeated too often: find out more
Image SEO
(Somewhat important)
Alt text (alternative text) is correctly used on all found images.
Social Networks
(Nice to have)
There are only a few social sharing widgets on the page. Make your website popular in social networks with social sharing widgets.
Additional markup
(Nice to have)
No additional page markup was found.
HTTPS
(Somewhat important)
This website uses HTTPS to protect privacy and integrity of the exchanged data.
All included files are also transferred via HTTPS.

Media list

URLAlt attributeTitle
...054162cb1dd2807ef9d39eee5effe406-720x257Takeda logo
...:eco/f_auto/v1/Global/Our_Company_gl09yyCEO Letter to Shareholders
data:[...] Base64two women in a laboratory
data:[...] Base64People shaking hands in office
data:[...] Base64man in labcoat
...054162cb1dd2807ef9d39eee5effe406-720x257Takeda logo

Page structure

H1 heading
(Critically important)
Takeda Pharmaceuticals: Global Homepage
The H1 heading is perfect.
Headings
(Important)
The heading structure is perfect.

Heading structure

Heading levelContent
H1 Takeda Pharmaceuticals: Global Homepage
H2 Notice of 148th Annual General Shareholder Meeting
H2 Recent News
H2 Better Health, Brighter Future
H2 Our Areas of Focus
H2 Sign up for investors newsletter
H3 Notice Regarding Pricing of JPY Hybrid Bonds
H3 Takeda’s TAK-861 Phase 2b Late-Breaking Data Presentations at SLEEP 2024 Demonstrate Clinically Meaningful Impact of Oral Orexin Agonist in Narcolepsy Type 1 Compared to Placebo
H3 Notice Concerning Withdrawal of Shelf Registration Statement and Filing of New Shelf Registration Statement in Japan
H3 Takeda and Pfizer Announce Four-Year Results from Positive Phase 3 HD21 Trial of Additional ADCETRIS® (brentuximab vedotin) Combination in Frontline Hodgkin Lymphoma
H3 Join Us
H3 Investors
H3 R&D
H3 Gastrointestinal and Inflammation
H3 Rare Diseases
H3 Plasma-Derived Therapies
H3 Oncology
H3 Neuroscience
H3 Vaccines
Some internal link anchor texts are too long.
Some anchor texts are used more than once.
The number of internal links is ok.
All internal links are not using dynamic parameters.
There are 2 external links on this page.

Found links on this page

LinkAttributesAnchor text
https://www.takeda.com/IMG-ALT Takeda logo
/about/our-company/Our Company
/about/leadership/Leadership
/about/corporate-responsibilit...Sustainability Approach
/about/corporate-responsibilit...Access to Medicines
/about/corporate-responsibilit...Sustainability Disclosures
/about/corporate-responsibilit...Ethics
/about/corporate-responsibilit...Transparency Disclosures
/about/corporate-responsibilit...Positions
/about/corporate-responsibilit...Corporate Giving
/about/corporate-governance/st...Governance Strategy
/about/corporate-governance/go...Governance Structure
/about/corporate-governance/ch...Charters and Reports
/science/areas-of-focus/Areas of Focus
/science/research-and-developm...Research and Development
/science/pipeline/Pipeline
/science/products/Our Products
/science/products/manufacturing/Manufacturing
/science/products/suppliers/Suppliers
/science/clinical-trials/Clinical Trials
/our-impact/our-stories/Our Stories
/newsroom/press-releases/Press Releases
/newsroom/statements/Statements
/newsroom/media-resources/Media Resources
/investors/overview/Overview
/investors/financial-results/q...Financial Results
/investors/events/Investor Events
/investors/contact/Investor Contact
https://www.takeda.com/careers/Careers
/about/our-company/Text duplicate Our Company
/about/leadershipText duplicate Leadership
/about/corporate-responsibilit...Text duplicate Sustainability Approach
/about/corporate-responsibilit...Text duplicate Access to Medicines
/about/corporate-responsibilit...Text duplicate Sustainability Disclosures
/about/corporate-responsibilit...Text duplicate Ethics
/about/corporate-responsibilit...Text duplicate Transparency Disclosures
/about/corporate-responsibilit...Text duplicate Positions
/about/corporate-responsibilit...Text duplicate Corporate Giving
/about/corporate-governance/st...Text duplicate Governance Strategy
/about/corporate-governance/go...Text duplicate Governance Structure
/about/corporate-governance/ch...Text duplicate Charters and Reports
/science/areas-of-focus/Text duplicate Areas of Focus
/science/research-and-developmentText duplicate Research and Development
/science/pipelineText duplicate Pipeline
/science/productsText duplicate Our Products
/science/products/manufacturingText duplicate Manufacturing
/science/products/suppliersText duplicate Suppliers
/science/clinical-trialsText duplicate Clinical Trials
/our-impact/our-storiesText duplicate Our Stories
/newsroom/press-releasesText duplicate Press Releases
/newsroom/statementsText duplicate Statements
/newsroom/media-resourcesText duplicate Media Resources
/investors/overviewText duplicate Overview
/investors/financial-results/q...Text duplicate Financial Results
/investors/eventsText duplicate Investor Events
/investors/contactText duplicate Investor Contact
https://www.takeda.com/careersText duplicate Careers
/investors/events/New window Subdomain Anchor Learn More
/newsroom/newsreleases/2024/no...Notice Regarding Pricing of JPY Hybrid Bonds June 7, 2024
/newsroom/newsreleases/2024/ta...Takeda’s TAK-861 Phase 2b Late-Breaking Data Presentations at SLEEP 2024 Demonstrate Clinically Meaningful Impact of Oral Orexin Agonist in Narcolepsy Type 1...
/newsroom/newsreleases/2024/no...Notice Concerning Withdrawal of Shelf Registration Statement and Filing of New Shelf Registration Statement in Japan June 3, 2024
/newsroom/newsreleases/2024/fo...Takeda and Pfizer Announce Four-Year Results from Positive Phase 3 HD21 Trial of Additional ADCETRIS® (brentuximab vedotin) Combination in Frontline Hodgkin ...
/newsroom/press-releasesView All
https://www.takeda.com/careers/IMG-ALT two women in a laboratory
https://www.takeda.com/careers/Join Us
https://www.takeda.com/careers/FIND OUT MORE
/investors/overview/IMG-ALT People shaking hands in office
/investors/overview/Investors
/investors/overview/Text duplicate FIND OUT MORE
/science/research-and-developm...IMG-ALT man in labcoat
/science/research-and-developm...R&D
/science/research-and-developm...Text duplicate FIND OUT MORE
/science/areas-of-focus/gastro...Gastrointestinal and Inflammation Understanding and addressing life-limiting gastrointestinal and inflammatory diseases
/science/areas-of-focus/rare-d...Rare Diseases Working to transform treatments in immunology, hematology, metabolic and lysosomal storage disorders
/science/areas-of-focus/pdt/Plasma-Derived Therapies Improving the lives of patients with rare and complex chronic diseases through innovation in plasma
/science/areas-of-focus/oncology/Oncology Aspiring to cure cancer, with inspiration from patients and innovation from everywhere
/science/areas-of-focus/neuros...Neuroscience Driving medical innovation for patients with neurological diseases
/science/areas-of-focus/vaccines/Vaccines Addressing unmet global health needs through vaccine development against infectious diseases
/investors/newsletter/Sign up
https://www.takeda.com/Text duplicate IMG-ALT Takeda logo
https://www.linkedin.com/compa...New window External Subdomain No Text
https://www.youtube.com/takeda...New window External Subdomain No Text
https://www.takeda.com/worldwide/Locations
/contact-us/Contact us
https://www.takeda.com/careers/Text duplicate Careers
/investors/financial-highlights/Financial Highlights
https://www.takeda.com/hcps/HCPs
https://www.takeda.com/patients/Patients
https://www.takeda.com/worldwide/country selector
/terms-and-conditions/Terms and Conditions
/privacy-notice/Privacy Notice
/cookie-policy/Cookie Policy
/global-accessibility-statement/Accessibility Statement

Server configuration

HTTP redirects
(Critically important)
This page redirects to "https://www.takeda.com/"
HTTP header
(Important)
The X-powered header is sent within the response header. (unnecessary)
This page uses GZip for compressed data transmission.
Performance
(Somewhat important)
The page response time is excellent with 0.27 seconds.
The file size of the HTML document is fine (440 kB).

HTTP Response Header

NameValue
dateFri, 07 Jun 2024 02:24:24 GMT
content-typetext/html; charset=utf-8
cf-ray88fd2f87cb0b39ec-FRA
cf-cache-statusDYNAMIC
age402
cache-controlpublic, max-age=0, must-revalidate
strict-transport-securitymax-age=63072000; includeSubDomains; preload
x-matched-path/en
x-powered-byNext.js
x-vercel-cacheHIT
x-vercel-idfra1::iad1::hrzhp-1717727064314-c44ddc8b0e80
set-cookie259 Characters
varyAccept-Encoding
servercloudflare
content-encodinggzip
statuscode200
http_versionHTTP/2

External factors

Blacklists
(Nice to have)
This website is not classified "for adult only".
This page is referenced by wikipedia.
This website has excellent links from other websites.
This page has backlinks from 12,641 referring domains.
This page has 2,521,911 backlinks.
This page has backlinks from 7,588 different ip addresses.
Facebook popularity
(Somewhat important)
The page has 1350 shares and comments on Facebook.

Links from Wikipedia

You can find more links using Wikipedia search

Robots.txt

# *
User-agent: *
Disallow: /*?
Disallow: /search?query=*
Disallow: /elmah.axd
Disallow: /admui/
Disallow: /util/
Disallow: /pingfederate
Disallow: /pingfederate/
Disallow: /ja-jp/research-support/
Disallow: /ja-jp/educational-support/
Disallow: /en-gb/hcps/privacy/
Disallow: /en-gb/hcps//subscribed/
Disallow: /en-ie/hcps/privacy/
Disallow: /en-ie/hcps/subscribed/
Disallow: /siteassets/system/privacy-notice/takedaprivacynotice_en.pdf
Disallow: /siteassets/es-es/home/what-we-do/transparencia/de-valor-2019/er-03185es_v2_24junio-2020def.pdf
Disallow: /siteassets/es-es/home/what-we-do/transparencia/de-valor-2019/er-03185en_v2_24junio_2020def.pdf
Disallow: /siteassets/es-es/home/what-we-do/transparencia/shire-transparencia/reports/shire-report-spain2019-spanish.pdf
Disallow: /siteassets/es-es/home/what-we-do/transparencia/shire-transparencia/reports/shire-report-spain2019-english.pdf
Disallow: /it-it/le-nostre-storie/associazioni-di-pazienti/
Disallow: /es-es/transparencia/colaboracion-con-asociaciones-de-pacientes-shire/
Disallow: /siteassets/es-es/home/what-we-do/transparencia/colaboracion-asoc-pacientes-shire_2019.pdf
Disallow: /es-es/transparencia/colaboracion-con-asociaciones-de-pacientes-shire/colaboracion-con-asociaciones-de-pacientes-2018-shire/
Disallow: /es-es/transparencia/colaboracion-con-asociaciones-de-pacientes-shire/colaboracion-con-asociaciones-de-pacientes-2017-Shire/
Disallow: /es-es/transparencia/colaboracion-con-asociaciones-de-pacientes-shire/colaboracion-con-asociaciones-de-pacientes-2016-Shire/
Disallow: /es-es/transparencia/colaboracion-con-asociaciones-de-pacientes-shire/colaboracion-con-asociaciones-de-pacientes-2016-Baxalta/
Disallow: /es-es/transparencia/colaboracion-con-asociaciones-de-pacientes-shire/colaboracion-con-asociaciones-de-pacientes-2015-Shire/
Disallow: /es-es/transparencia/colaboracion-con-asociaciones-de-pacientes-shire/colaboracion-con-asociaciones-de-pacientes-2014-shire/
Disallow: /es-es/transparencia/colaboracion-con-asociaciones-de-pacientes-shire/colaboracion-con-asociaciones-de-pacientes-2013-shire/
Disallow: /siteassets/es-es/home/what-we-do/transparencia/Shire-transparencia/Reports/baxalta-report-spain2015-spanish.pdf
Disallow: /siteassets/es-es/home/what-we-do/transparencia/Shire-transparencia/Reports/baxalta-report-spain2016-english.pdf
Disallow: /siteassets/es-es/home/what-we-do/transparencia/Shire-transparencia/Reports/baxalta-report-spain2016-spanish.pdf
Disallow: /siteassets/es-es/home/what-we-do/transparencia/Shire-transparencia/Reports/report-spain-english.pdf
Disallow: /siteassets/es-es/home/what-we-do/transparencia/Shire-transparencia/Reports/report-spain-spanish.pdf
Disallow: /siteassets/es-es/home/what-we-do/transparencia/Shire-transparencia/Reports/shire-report-2018-spain-english.pdf
Disallow: /siteassets/es-es/home/what-we-do/transparencia/Shire-transparencia/Reports/shire-report-2018-spain-spanish.pdf
Disallow: /siteassets/es-es/home/what-we-do/transparencia/Shire-transparencia/Reports/shire-report-spain2015-english.pdf
Disallow: /siteassets/es-es/home/what-we-do/transparencia/Shire-transparencia/Reports/shire-report-spain2015-spanish.pdf
Disallow: /siteassets/es-es/home/what-we-do/transparencia/Shire-transparencia/Reports/shire-report-spain2016-english.pdf
Disallow: /siteassets/es-es/home/what-we-do/transparencia/Shire-transparencia/Reports/shire-report-spain2016-spanish.pdf
Disallow: /siteassets/it-it/home/our-stories/tranzparence/2018_shire-efpia-report_italian.pdf
Disallow: /siteassets/it-it/home/our-stories/tranzparence/2017_shire_efpia-report_italian.pdf
Disallow: /siteassets/it-it/home/our-stories/tranzparence/2016_shire_fpia-report_italian.pdf
Disallow: /siteassets/it-it/home/our-stories/tranzparence/2016_baxalta-report_italian.pdf
Disallow: /siteassets/it-it/home/our-stories/tranzparence/2015_shire_efpia-report_italian.pdf
Disallow: /en-gb/hcps/chatbot-terms
Disallow: /en-gb/hcps/chatbot-privacy-notice
Disallow: /siteassets/en-gb/home/hcps/pi/vipidia_vipdomet_pi.pdf
Disallow: /siteassets/en-gb/home/hcps/pi/replagal_pi.pdf 
Disallow: /siteassets/en-gb/home/hcps/pi/VPRIV_pi.pdf
Disallow: /siteassets/en-gb/home/hcps/pi/TAKHZYRO_pi.pdf
Disallow: /en-gb/mental-health-webinar-series-practitioner-mental-well-being/
Disallow: /siteassets/system/biolife/us-new-hire-paperwork-checklist_biolifeplasmaservices.pdf
Disallow: /siteassets/system/biolife/instructions-for-tasks-to-complete-within-24-hours_biolifeplasmaservices.pdf
Disallow: /siteassets/system/biolife/instructions-for-tasks-to-complete-within-48-hours_biolifeplasmaservices.pdf
Disallow: /siteassets/system/biolife/2020-benefits-information_biolifeplasmaservices.pdf
Disallow: /siteassets/system/biolife/douments-to-review-prior-to-start_biolifeplasmaservices.pdf
Disallow: /siteassets/en-gb/home/hcps/pi/*.pdf
Disallow: /siteassets/en-gb/home/hcps/pi/hyqvia-pi.pdf
Disallow: /siteassets/en-gb/home/hcps/pi/cuvitru-pi.pdf
Disallow: /siteassets/en-gb/home/hcps/pi/uk-prostapdcs-breast-cancer-and-ovarian.pdf
Disallow: /siteassets/en-gb/home/hcps/pi/uk-prostap-dcs-all-indications.pdf
Disallow: /siteassets/en-gb/home/hcps/pi/elaprase_pi.pdf
Disallow: /siteassets/en-gb/home/hcps/pi/cinryze-pi.pdf
Disallow: /siteassets/en-gb/home/hcps/pi/firazyr-pi.pdf
Disallow: /siteassets/en-gb/home/hcps/pi/kiovig-pi.pdf
Disallow: /siteassets/en-gb/home/hcps/pi/revestive_pi.pdf
Disallow: /siteassets/en-gb/home/hcps/pi/uk-prostap_dcs_gynaecological_indications.pdf
Disallow: /siteassets/en-gb/home/hcps/pi/uk-prostap_dcs_prostate-cancer_pi.pdf
Disallow: /en-ie/frailty-assessment-and-sequencing-in-patients-with-transplant-ineligible-multiple-myeloma-1
Disallow: /en-ie/frailty-assessment-and-sequencing-in-patients-with-transplant-ineligible-multiple-myeloma-2
Disallow: /siteassets/en-us/home/external-reference/InfluenzaConsentForm/influenza-2021-2022-consent-form-english.pdf
Disallow: /siteassets/en-us/home/external-reference/InfluenzaConsentForm/influenza-2021-2022-consent-form-spanish.pdf
Disallow: /siteassets/en-us/home/external-reference/InfluenzaConsentForm/influenza-vis-english.pdf
Disallow: /siteassets/en-us/home/external-reference/InfluenzaConsentForm/influenza-vis-spanish.pdf

# Host
Host: https://www.takeda.com

# Sitemap
Sitemap: https://www.takeda.com/sitemap.xml

Similar sites

Search preview

www.takeda.com
Takeda Pharmaceuticals: Global Homepage
Takeda is a patient-focused, R&D-driven global biopharmaceutical company committed to bringing Better Health and a Brighter Future.

Most important keywords

Following keywords were found. You can check the keyword optimization of this page for each keyword.

KeywordResultRecheck
Takeda93%Check
Takeda Pharmaceuticals79%Check
GLOBAL75%Check
Global Homepage68%Check
Pharmaceuticals62%Check
Global Health62%Check
Pharmaceutical Company60%Check
health50%Check
better50%Check
brighter50%Check
Show more keywords and terms

Test up to 1.000 webpages of takeda.com with our free plan!

Try For Free
No trial. It's just free!

Cookie Policy

We use cookies to make our site work and also for analytics and advertising purposes. You can enable or disable optional cookies as desired. See the following links for more information.

Contact | Privacy

We need these so the site can function properly

So we can better understand how visitors use our website

So we can serve you tailored ads and promotions